Richard Friedman to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Richard Friedman has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.467
-
Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials. Orthopedics. 2011 Oct; 34(10):795-804.
Score: 0.365
-
Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty. Clin Appl Thromb Hemost. 2009 Sep-Oct; 15 Suppl 1:25S-31S.
Score: 0.078
-
Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis. Thromb Res. 2012 Nov; 130(5):818-20.
Score: 0.024